Cargando…

Acute pulmonary thromboembolism after messenger RNA vaccination against coronavirus disease 2019: A case report

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is defined as thrombosis after inoculation of adenovirus vector vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VITT rarely occurs with messenger RNA vaccines, and the use of heparin for VITT is also controversi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishibashi, Yohei, Takama, Noriaki, Fujii, Takaaki, Takizawa, Daiki, Amanai, Shiro, Kuno, Takahiro, Aihara, Kazufumi, Koitabashi, Norimichi, Ishii, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese College of Cardiology 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939391/ https://www.ncbi.nlm.nih.gov/pubmed/36846298 http://dx.doi.org/10.1016/j.jccase.2023.02.014

Ejemplares similares

Drug-coated balloons for the treatment of stent edge restenosis
por: Nagasaka, Takashi, et al.
Publicado: (2023)

Acute myocarditis associated with COVID-19 vaccination: A case report
por: Nagasaka, Takashi, et al.
Publicado: (2021)

A case of a middle-aged patient with a ventricular septal defect complicated by severe pulmonary hypertension-stepwise surgical repair with pulmonary vasodilators-
por: Kanai, Anna, et al.
Publicado: (2021)

Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment
por: Koitabashi, Norimichi, et al.
Publicado: (2015)

Adaptive Servo-ventilation Therapy Results in the Prevention of Arrhythmias in Patients with Heart Failure Due to Ischemic Heart Disease
por: Nagasaka, Takashi, et al.
Publicado: (2021)

Nonbacterial Thrombotic Endocarditis—A Rare Case of Acute Libman-Sacks Endocarditis Complicated by Multiple Cerebral Infarcts: Case Report and Literature Review
por: Kato, Toshimitsu, et al.
Publicado: (2020)

Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure
por: Matsuo, Yae, et al.
Publicado: (2016)

Effects of Statin Therapy on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients With Chronic Heart Failure: A Propensity Score-Matched Analysis
por: Sano, Hirokazu, et al.
Publicado: (2014)

Effect of Inferior Vena Cava Filter on Venous Thromboembolism Mortality in Japan　― JROAD and JROAD-DPC Registry Analysis ―
por: Ohyama, Yoshiaki, et al.
Publicado: (2019)

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021)

Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
por: Fujii, Masayoshi, et al.
Publicado: (2023)

Pressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes
por: Matsui, Hiroki, et al.
Publicado: (2012)

Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
por: Ogo, Takeshi, et al.
Publicado: (2022)

Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications
por: Koizume, Shiro, et al.
Publicado: (2022)

Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
por: de Chaisemartin, Luc, et al.
Publicado: (2022)

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
por: Florea, Ana, et al.
Publicado: (2022)

Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination
por: Miyazaki, Koji, et al.
Publicado: (2023)

Treatment of pulmonary thromboembolism with edoxaban in a cancer patient with borderline fulfillment of the dose reduction criteria
por: Takama, Takuro, et al.
Publicado: (2019)

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022)

Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age
por: Das, Bibhuti B., et al.
Publicado: (2021)

Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Long-term evaluation of sperm parameters after coronavirus disease 2019 messenger ribonucleic acid vaccination
por: Diaz, Parris, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
por: Su, Wei-Ju, et al.
Publicado: (2023)

Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis
por: Di Renzo, Gian Carlo, et al.
Publicado: (2020)

Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis
por: Schiaffino, Simone, et al.
Publicado: (2021)

Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019
por: Thondapu, Vikas, et al.
Publicado: (2021)

Brugada phenocopy with altered ST-segment elevation in pericardial diffuse large B-cell lymphoma and effusive–constrictive pericarditis: a case report
por: Ishibashi, Yohei, et al.
Publicado: (2023)

Validation of a Five-Year Prognostic Model Using (123)I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure
por: Ishibashi, Yohei, et al.
Publicado: (2023)

The Coronavirus Disease 2019 Likelihood of Thrombosis Calculator: Predicting Venous Thromboembolism Risk in Hospitalized Patients With Coronavirus Disease 2019
por: Meena, Richard A., et al.
Publicado: (2021)

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
por: Wong, Serre-Yu, et al.
Publicado: (2021)

Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination
por: Kahn, Benjamin, et al.
Publicado: (2021)

Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers
por: St. Clair, Benjamin D., et al.
Publicado: (2022)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

neutrinos as messengers
por: Ahlers, Markus
Publicado: (2018)

Zinc messenger
por: Powell, Kendall
Publicado: (2007)

Destroying the messenger
por: Wells, William A.
Publicado: (2007)

Messenger of safety.
por: Clay, R
Publicado: (1998)

Unmasking the messenger
por: Hutten, Saskia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lilt5bnce1v3bsojdb6jpsf9h1